BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 19094851)

  • 21. Tyrosinase gene mutations in type I (tyrosinase-deficient) oculocutaneous albinism define two clusters of missense substitutions.
    Tripathi RK; Strunk KM; Giebel LB; Weleber RG; Spritz RA
    Am J Med Genet; 1992 Jul; 43(5):865-71. PubMed ID: 1642278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genotype-phenotype associations in Danish patients with ocular and oculocutaneous albinism.
    Kessel L; Kjer B; Lei U; Duno M; Grønskov K
    Ophthalmic Genet; 2021 Jun; 42(3):230-238. PubMed ID: 33612058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic analyses of oculocutaneous albinism types 1 and 2 with four novel mutations.
    Yang Q; Yi S; Li M; Xie B; Luo J; Wang J; Rong X; Zhang Q; Qin Z; Hang L; Feng S; Fan X
    BMC Med Genet; 2019 Jun; 20(1):106. PubMed ID: 31196117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutations in the human orthologue of the mouse underwhite gene (uw) underlie a new form of oculocutaneous albinism, OCA4.
    Newton JM; Cohen-Barak O; Hagiwara N; Gardner JM; Davisson MT; King RA; Brilliant MH
    Am J Hum Genet; 2001 Nov; 69(5):981-8. PubMed ID: 11574907
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evident hypopigmentation without other ocular deficits in Dutch patients with oculocutaneous albinism type 4.
    Kruijt CC; Schalij-Delfos NE; de Wit GC; Florijn RJ; van Genderen MM
    Sci Rep; 2021 Jun; 11(1):11572. PubMed ID: 34078970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular basis of type I (tyrosinase-related) oculocutaneous albinism: mutations and polymorphisms of the human tyrosinase gene.
    Oetting WS; King RA
    Hum Mutat; 1993; 2(1):1-6. PubMed ID: 8477259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ophthalmic features of minimal pigment oculocutaneous albinism.
    Summers CG; King RA
    Ophthalmology; 1994 May; 101(5):906-14. PubMed ID: 8190479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutational Analysis of TYR, OCA2, and SLC45A2 Genes in Chinese Families with Oculocutaneous Albinism.
    Lin Y; Chen X; Yang Y; Che F; Zhang S; Yuan L; Wu Y
    Mol Genet Genomic Med; 2019 Jul; 7(7):e00687. PubMed ID: 31199599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Albinism: classification, clinical characteristics, and recent findings.
    Summers CG
    Optom Vis Sci; 2009 Jun; 86(6):659-62. PubMed ID: 19390472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NGS-based targeted sequencing identified two novel variants in Southwestern Chinese families with oculocutaneous albinism.
    Xiao Y; Zhou C; Xie H; Huang S; Wang J; Liu S
    BMC Genomics; 2022 Apr; 23(1):332. PubMed ID: 35488210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular basis of albinism in India: evaluation of seven potential candidate genes and some new findings.
    Mondal M; Sengupta M; Samanta S; Sil A; Ray K
    Gene; 2012 Dec; 511(2):470-4. PubMed ID: 23010199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expanding the Spectrum of Oculocutaneous Albinism: Does Isolated Foveal Hypoplasia Really Exist?
    Rocca C; Tiberi L; Bargiacchi S; Palazzo V; Landini S; Marziali E; Caputo R; Tinelli F; Marchi V; Benedetto A; Pagliazzi A; Bacci GM
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutation analysis of the tyrosinase gene in oculocutaneous albinism.
    Camand O; Marchant D; Boutboul S; PĂ©quignot M; Odent S; Dollfus H; Sutherland J; Levin A; Menasche M; Marsac C; Dufier JL; Heon E; Abitbol M
    Hum Mutat; 2001 Apr; 17(4):352. PubMed ID: 11295837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Phenotypic Spectrum of Albinism.
    Kruijt CC; de Wit GC; Bergen AA; Florijn RJ; Schalij-Delfos NE; van Genderen MM
    Ophthalmology; 2018 Dec; 125(12):1953-1960. PubMed ID: 30098354
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of a functionally significant tri-allelic genotype in the Tyrosinase gene (TYR) causing hypomorphic oculocutaneous albinism (OCA1B).
    Norman CS; O'Gorman L; Gibson J; Pengelly RJ; Baralle D; Ratnayaka JA; Griffiths H; Rose-Zerilli M; Ranger M; Bunyan D; Lee H; Page R; Newall T; Shawkat F; Mattocks C; Ward D; Ennis S; Self JE
    Sci Rep; 2017 Jun; 7(1):4415. PubMed ID: 28667292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ophthalmo-genetic analysis of Pakistani patients with nonsyndromic oculocutaneous albinism through whole exome sequencing.
    Gul H; Ali MZ; Khan E; Zubair M; Badar M; Khan S; Shah AH; Khan MA
    J Pak Med Assoc; 2017 May; 67(5):790-792. PubMed ID: 28507374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tyrosinase gene mutations in oculocutaneous albinism 1 (OCA1): definition of the phenotype.
    King RA; Pietsch J; Fryer JP; Savage S; Brott MJ; Russell-Eggitt I; Summers CG; Oetting WS
    Hum Genet; 2003 Nov; 113(6):502-13. PubMed ID: 13680365
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.